Skip to main content
Bristol Myers Squibb10-Q: Goodwill impairment

Incurred $410 Million in IPRD Impairment Charges in Q1 2026

Source: Autobound Signal API · 118 signals tracked for Bristol Myers Squibb · updated

Get Bristol Myers Squibb's live signals in Claude or ChatGPT, or by API

AskWhat changed at Bristol Myers Squibb this week? Use Autobound signals for bms.com.

What happened

Research and development expenses increased by $393 million in Q1 2026 primarily due to $410 million in IPRD impairment charges.

Source

SEC EDGARApr 30, 2026

Quarterly report (Form 10-Q)

Bristol Myers Squibb 10-Q for Quarter ended Mar 31, 2026

Filing excerpt

Research and development expense increased by $393 million in the first quarter of 2026, primarily due to IPRD impairment charges of $410 million, partially offset by cost savings from the Company's ongoing strategic productivity initiative.

sec.gov/Archives/edgar/data/14272/000001427226000010/bmy-20260331.htmRead the full source

Other signals in this filing (5)

Extracted by Autobound

From the Signal API record
Signal
10-Q: Goodwill impairment

What this signalsFilings often name leadership changes, deals and spending plans.

Period
Quarter ended Mar 31, 2026
Fiscal year end
03/31
Filed
Apr 30, 2026

More 10-Q signals at other companies

The full record

From the Signal API record

Numbers

Dollar figure
$410M (IPRD impairment charges)

Details

CIK
14272
Accession number
0000014272-26-000010
Timeframe
Current quarter
Quarter
Q1
Filing year
2026
Period end date
Mar 31, 2026
Why it matters
Strategic review underway
Signal category
Financial

Extraction

Confidence
High
Relevance
75%
Sentiment
Negative
Detected
Nov 9, 2026
signal_type
sec-10q
signal_subtype
goodwillImpairment

Use this data

Get every 10-Q signal for Bristol Myers Squibb and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Bristol Myers Squibb this week?”

  2. Send it to your own tools

    The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/f4230a86-9f7b-4be1-98fb-1ffdfd7fa9e9 returns this record as JSON. POST /v1/companies/enrich returns every signal for bms.com.

{
  "signal_id": "f4230a86-9f7b-4be1-98fb-1ffdfd7fa9e9",
  "signal_type": "sec-10q",
  "signal_subtype": "goodwillImpairment",
  "detected_at": "2026-11-09T06:24:49.499+00:00",
  "company": {
    "name": "Bristol Myers Squibb",
    "domain": "bms.com"
  },
  "data": {
    "detail": "Research and development expenses increased by $393 million in Q1 2026 primarily due to $410 million in IPRD impairment charges. Portfolio adjustments and clinical write-downs may prompt BMS to evaluate new clinical intelligence and pipeline optimization vendors.",
    "metrics": {
      "timeframe": "current_quarter",
      "dollar_context": "IPRD impairment charges",
      "dollar_millions": 410
    },
    "quarter": "Q1",
    "summary": "Incurred $410 Million in IPRD Impairment Charges in Q1 2026",
    "excerpts": "Research and development expense increased by $393 million in the first quarter of 2026, primarily due to IPRD impairment charges of $410 million, partially offset by cost savings from the Company's ongoing strategic productivity initiative.",
    "relevance": 0.75,
    "sentiment": "negative",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/14272/000001427226000010/bmy-20260331.htm",
    "filing_date": "2026-04-30",
    "filing_year": 2026,
    "fiscal_year": 2026,
    "fiscal_year_end": "03/31",
    "period_end_date": "2026-03-31",
    "sales_relevance": "Strategic review underway",
    "signal_category": "financial"
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.